Pharmacogenomics and Functional Gastrointestinal Disorders
- 1 July 2005
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 6 (5) , 491-501
- https://doi.org/10.2217/14622416.6.5.491
Abstract
Functional gastrointestinal disorders, including irritable bowel syndrome and functional dyspepsia, are highly prevalent disorders affecting approximately one in four people in Western societies. This article reviews examples of the role of pharmacogenomics in the safety and efficacy of medications used in the management of such disorders. These include variations in the effects of medications metabolized by cytochrome P450 enzymes (e.g., 2D6 and 2C19), and the effects of genetic polymorphisms in the promoter of the serotonin transporter protein, which influence the response to alosetron in patients with diarrhea-predominant irritable bowel syndrome. These observations suggest that pharmacogenomics will introduce a new era in pharmacotherapeutics in gastroenterology.Keywords
This publication has 57 references indexed in Scilit:
- A community-based, controlled study of the epidemiology and pathophysiology of dyspepsiaClinical Gastroenterology and Hepatology, 2004
- Is there a SERT-ain association with IBS?Gut, 2004
- Genetic Predictors of the Clinical Response to Opioid AnalgesicsClinical Pharmacokinetics, 2004
- Drug AddictionNew England Journal of Medicine, 2003
- Evidence-based subtypes in functional dyspepsia with confirmatory factor analysis: Psychosocial and physiopathological correlatesGastroenterology, 2001
- Familial Association in Adults With Functional Gastrointestinal DisordersMayo Clinic Proceedings, 2000
- The 5-HT3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised ratGut, 2000
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Serotonergic mediation of postprandial colonic tonic and phasic responses in humans.Gut, 1994
- U. S. Householder survey of functional gastrointestinal disordersDigestive Diseases and Sciences, 1993